Comparative effects of topiroxostat and febuxostat on arterial properties in hypertensive patients with hyperuricemia

Elevated serum uric acid is a cardiovascular risk factor in patients with hypertension, even when blood pressure (BP) is well controlled. Xanthine oxidoreductase inhibitors (XORi) reduce serum uric acid levels and have several other potential effects. This multicenter, randomized, open‐label study c...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:J Clin Hypertens (Greenwich)
Asıl Yazarlar: Kario, Kazuomi, Nishizawa, Masafumi, Kiuchi, Mari, Kiyosue, Arihiro, Tomita, Fumishi, Ohtani, Hiroshi, Abe, Yasuhisa, Kuga, Hideyo, Miyazaki, Satoshi, Kasai, Takatoshi, Hongou, Makiko, Yasu, Takanori, Kuramochi, Jin, Fukumoto, Yoshihiro, Hoshide, Satoshi, Hisatome, Ichiro
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: John Wiley and Sons Inc. 2021
Konular:
Hyperuricemia
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC8029836/
https://ncbi.nlm.nih.gov/pubmed/33400348
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jch.14153
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller